Article Details
Retrieved on: 2021-06-15 13:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Truist Securities boosted their target price on shares of Dicerna Pharmaceuticals from $35.00 to $45.00 in a research report on Monday, April 19th.
Article found on: www.marketbeat.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here